06/12/2005

December City Presentation

10/10/2005

EGM Statement

28/09/2005

Research Update

22/09/2005

Declaration of Shareholding in ReGen Therapeutics Plc

20/09/2005

Declaration of Shareholding in ReGen Therapeutics Plc

15/09/2005

Committed Share Finance Facility

15/09/2005

ReGen Therapeutics Plc places £1,556,000 of shares

15/09/2005

Interim Results for the Six Months’ to 30 June 2005

10/08/2005

ReGen Therapeutics announces grant of U.S. patent on use of Colostrinin(tm) to promote induction of Cytokines

18/07/2005

ReGen Therapeutics Plc Appoints New Broker

27/06/2005

Research Update

20/06/2005

ReGen Achieves Production Scale-Up Milestone for Colostrinin(TM)

13/06/2005

Director Shareholding

09/06/2005

ReGen Acquires Rights To New Use for Well Known Drug

24/04/2005

Results of Annual General Meeting and Directorate Change

15/03/2005

Statement re ADR’s

08/03/2005

Regen Therapeutics Plc appoints additional non-executive director

04/03/2005

ReGen Therapeutics announces grant of U.S. patent on use of Colostrinin in Dementia

14/02/2005

Regen Therapeutics announces grant of U.S. patent on use of Colostrinin(tm) to promote neuronal cell differentiation

14/02/2005

Disclosure of notifiable interest – Disposal of shares

09/02/2005

Preliminary Results 2004

07/02/2005

Disclosure of notifiable interest – Disposal of shares

01/02/2005

Substantial shareholding